// App-Quantinova.ai

e18007 : Global Cancer Institute (GCI) multi-disciplinary tumor boards (MTBs) as an educational tool to improve guideline-based cancer clinical practice in low- and middle-income countries (LMICs).

Researchers

Presenter

  • Jessica St. Louis

Principal Investigators

  • Alexandra Bukowski

  • Rossana Esther Ruiz Mendoza

  • Carmen Herrero Vincent

  • Abraham Hernandez Blanquisett

  • Alphonse G. Taghian

  • Vered Stearns

  • Roisin Connolly

  • Ben Ho Park

  • Carol Marquez

  • Kathleen M. Schmeler

  • Anuja Jhingran

  • Marcela G. del Carmen

  • Thomas Christopher Randall

  • Don S. Dizon

  • Kathrin Strasser-Weippl

  • Paul E. Goss

Medical Centers

  • The Global Cancer Institute, Boston, MA

  • Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru

  • Valencian Institute of Oncology, Valencia, Spain

  • Massachusetts General Hospital, Boston, MA

  • School of Medicine and The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD

  • Kimmel Cancer Center at Johns Hopkins, Breast Cancer Program, Baltimore, MD

  • Breast and Ovarian Cancer Program, Kimmel Cancer Center at Johns Hopkins, Baltimore, MD

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • Division of Gynecologic Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA

  • Massachusetts General Hospital Cancer Center, Boston, MA

  • Wilheminen Hospital, Vienna, Austria

  • Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA

Locations

  • United States

  • Spain

  • Austria

  • Peru

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved